BE776769A - Composition pharmaceutique - Google Patents

Composition pharmaceutique

Info

Publication number
BE776769A
BE776769A BE776769A BE776769A BE776769A BE 776769 A BE776769 A BE 776769A BE 776769 A BE776769 A BE 776769A BE 776769 A BE776769 A BE 776769A BE 776769 A BE776769 A BE 776769A
Authority
BE
Belgium
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
BE776769A
Other languages
English (en)
French (fr)
Inventor
H J F Adams
B H Takman
Original Assignee
Astra Pharma Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Pharma Prod filed Critical Astra Pharma Prod
Publication of BE776769A publication Critical patent/BE776769A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE776769A 1971-01-26 1971-12-16 Composition pharmaceutique BE776769A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10994271A 1971-01-26 1971-01-26

Publications (1)

Publication Number Publication Date
BE776769A true BE776769A (fr) 1972-06-16

Family

ID=22330411

Family Applications (2)

Application Number Title Priority Date Filing Date
BE776769A BE776769A (fr) 1971-01-26 1971-12-16 Composition pharmaceutique
BE776768A BE776768A (fr) 1971-01-26 1971-12-16 Composition pharmaceutique

Family Applications After (1)

Application Number Title Priority Date Filing Date
BE776768A BE776768A (fr) 1971-01-26 1971-12-16 Composition pharmaceutique

Country Status (18)

Country Link
AT (2) AT310938B (enExample)
AU (1) AU465875B2 (enExample)
BE (2) BE776769A (enExample)
BR (2) BR7108429D0 (enExample)
CA (2) CA986012A (enExample)
DD (2) DD96144A5 (enExample)
DE (2) DE2163054C3 (enExample)
DK (2) DK130389B (enExample)
ES (2) ES398108A1 (enExample)
FR (2) FR2123277B1 (enExample)
GB (1) GB1370904A (enExample)
HU (2) HU162185B (enExample)
IE (2) IE35937B1 (enExample)
LU (1) LU64664A1 (enExample)
NL (2) NL7117401A (enExample)
NO (2) NO135891C (enExample)
SE (2) SE391286B (enExample)
ZA (2) ZA718326B (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998051290A3 (en) * 1997-05-16 1999-02-11 Childrens Medical Center Local anesthetic formulations comprising a site 1 sodium channel blocker combined with a second active agent
US8952152B2 (en) 2009-03-24 2015-02-10 Proteus S.A. Methods for purifying phycotoxins, pharmaceutical compositions containing purified phycotoxins, and methods of use thereof
US8975281B2 (en) 2013-03-15 2015-03-10 The Children's Medical Center Corporation Neosaxitoxin combination formulations for prolonged local anesthesia

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4917894A (en) * 1988-06-29 1990-04-17 Beecham Inc. Rapid-onset long-duration oral anesthetic composition
US6030974A (en) * 1997-04-02 2000-02-29 The Regents Of The University Of California Method of anesthesia
RU2277097C1 (ru) * 2004-12-27 2006-05-27 Институт Молекулярной Генетики Российской Академии Наук (Имг Ран) Высокомеченный тритием дигидрохлорид [3h]сакситоксина
CN101563079B (zh) 2006-03-27 2012-12-05 威克斯药业有限公司 钠通道阻滞剂在制备治疗由于化疗而产生的神经病理性疼痛的药物中的用途

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998051290A3 (en) * 1997-05-16 1999-02-11 Childrens Medical Center Local anesthetic formulations comprising a site 1 sodium channel blocker combined with a second active agent
US6326020B1 (en) 1997-05-16 2001-12-04 Children's Medical Center Corporation Local anesthetic formulations
US8952152B2 (en) 2009-03-24 2015-02-10 Proteus S.A. Methods for purifying phycotoxins, pharmaceutical compositions containing purified phycotoxins, and methods of use thereof
US8957207B2 (en) 2009-03-24 2015-02-17 Proteus S.A. Methods for producing phycotoxins
US9249150B2 (en) 2009-03-24 2016-02-02 Proteus S.A. Methods for purifying phycotoxins, pharmaceutical compositions containing purified phycotoxins, and methods of use thereof
US8975281B2 (en) 2013-03-15 2015-03-10 The Children's Medical Center Corporation Neosaxitoxin combination formulations for prolonged local anesthesia
US8975268B2 (en) 2013-03-15 2015-03-10 The Children's Medical Center Corporation Neosaxitoxin combination formulations for prolonged local anesthesia
US10314833B2 (en) 2013-03-15 2019-06-11 The Children's Medical Center Corporation Neosaxitoxin combination formulations for prolonged local anesthesia
US10881647B2 (en) 2013-03-15 2021-01-05 The Children's Medical Center Corporation Neosaxitoxin combination formulations for prolonged local anesthesia

Also Published As

Publication number Publication date
BR7108428D0 (pt) 1973-06-14
DK131606B (da) 1975-08-11
DD96144A5 (enExample) 1973-03-12
DE2163054B2 (de) 1978-06-01
BE776768A (fr) 1972-06-16
HU162185B (enExample) 1973-01-29
AT310938B (de) 1973-10-25
AU3710171A (en) 1973-06-28
IE35910L (en) 1972-07-26
ES398109A1 (es) 1975-03-16
ZA718326B (en) 1972-09-27
SE391127B (sv) 1977-02-07
DK131606C (da) 1976-01-12
DD96400A5 (enExample) 1973-03-20
FR2123277B1 (enExample) 1975-06-13
NO135892C (no) 1978-05-16
DE2163054A1 (de) 1974-05-02
BR7108429D0 (pt) 1973-06-14
DK130389C (enExample) 1975-07-14
DE2163055A1 (de) 1972-10-12
HU162347B (enExample) 1973-02-28
NO135892B (enExample) 1977-03-14
IE35937L (en) 1972-07-26
IE35910B1 (en) 1976-06-23
IE35937B1 (en) 1976-07-07
FR2123277A1 (enExample) 1972-09-08
AU3710071A (en) 1973-06-28
NL7117401A (enExample) 1972-07-28
DK130389B (da) 1975-02-17
FR2123278A1 (enExample) 1972-09-08
NO135891C (no) 1978-05-16
ZA718327B (en) 1972-09-27
NL7117404A (enExample) 1972-07-28
GB1370904A (en) 1974-10-16
FR2123278B1 (enExample) 1975-08-01
ES398108A1 (es) 1975-03-01
NO135891B (enExample) 1977-03-14
CA986012A (en) 1976-03-23
AU465875B2 (en) 1975-10-09
SE391286B (sv) 1977-02-14
DE2163054C3 (de) 1979-02-01
AT310939B (de) 1973-10-25
LU64664A1 (enExample) 1972-08-23
CA983850A (en) 1976-02-17

Similar Documents

Publication Publication Date Title
FI56487B (fi) Foerfarande foer framstaellning av en laett fluidiserbar inhalerbar farmaceutisk komposition
BE817126A (fr) Composition pharmaceutique fibrinolytique
BE789950A (fr) Composition photopolymerisable
RO77018A (ro) Compozitie fitotoxica
CH545223A (de) Flaschen-Harass
BE768269A (fr) Composition pharmaceutique
BG26673A3 (bg) Фотоколимеризуем състав
CH540643A (fr) Composition pesticide
BE793266A (fr) Composition photopolymerisable
FR2287223A1 (fr) Composition pharmaceutique
IE35991L (en) Camphor-containing pharmaceutical composition
BE782981A (fr) Compositions pharmaceutiques
DK143912C (da) Doseringsapparat
SE398198B (sv) Farmaceutisk anordning
IT966335B (it) Composizione disinfestante
FR2290196A1 (fr) Composition pharmaceutique
BE775640A (fr) Composition pharmaceutique
BE782444A (fr) Compositions pharmaceutiques
IT1050203B (it) Composizione antitraspirante
BE789658A (fr) Compositions polyurethanne-goudron
BE776768A (fr) Composition pharmaceutique
FR2100950A1 (fr) Composition pharmaceutique
BE775619A (fr) Compositions anesthesiques
TR18524A (tr) Fungisoksik maddeler
BE779323A (fr) Preparation hemostatique